Kontafarma China expects 1H net loss of HK$67.2 million-HK$100.7 million

• Kontafarma expects a consolidated net loss of HK$67.2 million to HK$100.7 million for the six months ended June 30, 2026.
• Compares with a net loss of about HK$321.4 million in the year-earlier period.
• Loss outlook driven by expected impairment charges of HK$51 million to HK$63.1 million tied to its Singapore fitness business.
• Prior-year result included HK$373.6 million of impairment losses for fitness operations in Taiwan and Singapore, versus lower charges this period.
• Singapore fitness unit faces tougher competition, higher customer acquisition costs; the group has been providing cash funding to support liquidity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12287633), on August 17, 2026, and is solely responsible for the information contained therein.